PTX3 and breast cancer: In the context of tumor-associated osteolysis, PTX3 expression (based on public genome-wide gene expression data) has been reported to be up-regulated in the distant bone metastases of breast cancer as compared to lung, liver and brain metastases (56, 57), and this has been linked to enhanced osteolysis (see below).